Study finds short window for donating convalescent plasma to COVID-19 patients

The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study. The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is […]

Read more

Transplant patients may not need steroid treatment in the long run

Long-term use of a medication used to treat kidney transplant patients may not be necessary in individuals with low-to-moderate risk of organ rejection, according to the results of a study led by a University of Cincinnati transplant researcher. The randomized clinical trial of 385 patients on immunosuppressive drugs tacrolimus and mycophenolate examined whether use of these medicines called corticosteroids could […]

Read more

Ideal surgical results less likely if cancer patients live in vulnerable communities

A new study finds that older cancer patients are less likely to have optimal results following their cancer operation if they live in an area highly affected by social challenges, especially if they are racial-ethnic minorities. The study was selected for the 2020 Southern Surgical Association Program and published as an article in press on the Journal of the American […]

Read more

Telemedicine needed to diagnose and treat dysphagia in COVID-19 patients, doctors say

COVID-19 and SARS-CoV-2, the virus behind the disease, have caused health care providers to change how they treat patients. Clinicians are now frequently using telemedicine to see their patients for routine checkups, saving office visits for emergencies. The same goes for rehabilitation. For example, researchers are looking for ways to improve the screening, assessment and treatment of patients with COVID-19 […]

Read more

Circulating tumor DNA indicates risk of relapse after transplant in DLBCL patients

Many patients with diffuse large B-cell lymphoma (DLBCL) can be cured by a transplant using their own blood-forming stem cells, but as many as half eventually relapse. New research led by Dana-Farber Cancer Institute scientists suggests that patients whose blood or stem cell samples harbor tumor DNA are likely to relapse. The findings, presented today at the virtual 62nd American […]

Read more

Patients with heart rhythm disorder warned against heavy alcohol consumption

Fourteen drinks a week is linked with a higher risk of health problems including stroke and embolism in patients with atrial fibrillation, according to research published in EP Europace, a journal of the European Society of Cardiology (ESC).1 “Our study suggests that atrial fibrillation patients should avoid heavy alcohol consumption to prevent stroke and other complications,” said author Dr. Boyoung […]

Read more

Risk for Fatal Cardiovascular Events High in Many T2DM Patients

WEDNESDAY, Dec. 2, 2020 — About half of patients with type 2 diabetes mellitus (T2DM) have a very high risk for fatal cardiovascular (CV) events, according to a research letter published online Nov. 13 in the European Journal of Preventive Cardiology. Ana M. Cebrián-Cuenca, M.D., Ph.D., from the Servicio Murciano de Salud in Cartagena, Spain, and colleagues conducted a cross-sectional […]

Read more
1 2 3 13